ASCVD Risk Stratification & LDL-C Target (China Lipid Guideline 2023) — free guideline decision tool
Determine ASCVD risk stratum and the corresponding LDL-C / non-HDL-C targets and initial lipid-lowering strategy, per the 2023 Chinese lipid-management guideline. Instant, browser-side.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does ASCVD Risk Stratification & LDL-C Target (China Lipid Guideline 2023) do?
Set an individualised LDL-C goal and lipid-lowering plan once risk stratum is known.
How is the result calculated?
LDL-C targets: extreme-high < 1.4, very-high < 1.8, high/intermediate < 2.6, low < 3.4 mmol/L (secondary-prevention strata also require ≥ 50% reduction). Non-HDL-C target = LDL-C target + 0.8 mmol/L.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run ASCVD Risk Stratification & LDL-C Target (China Lipid Guideline 2023) now
Determine ASCVD risk stratum and the corresponding LDL-C / non-HDL-C targets and initial lipid-lowering strategy, per the 2023 Chinese lipid-management guideline. Instant, browser-side.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.